Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

Not Applicable

Recruiting

• Conditions: Allergic Rhinitis
• Interventions: Behavioral: First group of heavy moxibustion; Behavioral: Second groups of heavy moxibustion; Behavioral: Ordinary moxibustion volume group

• Registration Number: NCT06173882
• Lead Sponsor: Henan University of Traditional Chinese Medicine

Brief Summary

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:

Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Detailed Description

Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.

Study Timeline

• Study Start: 2022-08-01
• Status Verified: 2023-12
• Study First Submitted: 2023-12-05
• Study First Submitted QC: 2023-12-15
• Last Update Submitted: 2023-12-15
• Study First Posted: 2023-12-18
• Last Update Posted: 2023-12-18
• Primary Completion: 2024-08-01
• Study Completion: 2025-08-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
First group of heavy moxibustion	First group of heavy moxibustion	-
Second groups of heavy moxibustion	Second groups of heavy moxibustion	-
Ordinary moxibustion volume group	Ordinary moxibustion volume group	-

Primary Outcome Measures

Name	Time	Method
Total nasal symptom scores（TNSS）	Change from baseline TNSS scores at week 0(before treatment)，4 and 12.	The main symptoms of allergic rhinitis, the higher the score, the worse the condition
Rhinitis VAS Visual Analog Scale（AR-VAS）	Change from baseline VAS scores at week 0(before treatment)，4 and 12.	VAS will be used to evaluate the relief of rhinitis symptoms, with a total score of 0-10. The higher the score, the more severe the symptoms will be

Secondary Outcome Measures

Name	Time	Method
Total non nasal symptom scores（TNNSS）	Change from baseline TNNSS scores at week0(before treatment)，4 and 12.	The nasal accompanying symptoms of allergic rhinitis, qualitative evaluation of the severity of the disease, with some indicating severity and none indicating milder severity
Detection of serum IgE and IL-33 levels	Week0(before treatment), week 4（after treatment）.	Immunoglobulin IgE and serum inflammatory cytokine IL-33 levels
Rhino-conjunctivitis Quality of Life Questionnaire （RQLQ）	Change from baseline RQLQ scores at week0(before treatment)，4 and 12.	RQLQ consists of 28 items, including daily life (1-3), sleep (4-6), non nasal eye symptoms (7-13), life problems (14-16), nasal symptoms (17-20), eye symptoms (21-24), and emotions (25-28). In the 7-point system, 1 point is the best and 7 points are the worst.

Trial Locations

Locations (1)

The First Affiliated Hospital of Henan University of Chinese Medicine; 🇨🇳 Zhengzhou, China